OPKO Health, Inc. (BMV:OPK)
Mexico · Delayed Price · Currency is MXN 20.86
0.00 (0.00%)
At close: Feb 27, 2026
OPKO Health Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -225.68 | -53.22 | -188.86 | -328.41 | -30.14 |
Depreciation & Amortization | 91.63 | 98.18 | 105.3 | 108.66 | 78.72 |
Other Amortization | 5.23 | 1.97 | 1.22 | 1.16 | 0.79 |
Loss (Gain) From Sale of Assets | -104.82 | -184.89 | 1.32 | -19.01 | -33.92 |
Asset Writedown & Restructuring Costs | 1.01 | - | - | - | - |
Loss (Gain) From Sale of Investments | 0.62 | -114.43 | 17.65 | 153.84 | 3.97 |
Loss (Gain) on Equity Investments | 0.03 | 0.02 | 0.11 | 0.38 | 0.63 |
Stock-Based Compensation | 10.71 | 11.05 | 11.41 | 18.51 | 13.63 |
Other Operating Activities | 83.91 | 25.66 | 1.86 | -72.97 | 25.16 |
Change in Accounts Receivable | 30.21 | -0.22 | 3.41 | 128.6 | 5.23 |
Change in Inventory | -4.12 | 4.22 | 15.2 | 13.66 | 30.68 |
Change in Accounts Payable | -14.22 | -20.66 | 2.83 | -9.39 | -10.85 |
Change in Unearned Revenue | - | - | - | - | -15.91 |
Change in Other Net Operating Assets | -53.06 | 48.84 | 0.36 | -90.22 | -29.64 |
Operating Cash Flow | -178.54 | -183.49 | -28.2 | -95.19 | 38.34 |
Operating Cash Flow Growth | - | - | - | - | -2.89% |
Capital Expenditures | -12.28 | -25.01 | -16.28 | -24.58 | -32.16 |
Sale of Property, Plant & Equipment | 198.06 | 210.62 | 2.71 | 1.95 | 66.03 |
Cash Acquisitions | - | - | - | -1.76 | -4 |
Investment in Securities | 44.52 | 166.6 | -4.64 | 115.42 | 6.08 |
Investing Cash Flow | 230.3 | 352.21 | -18.2 | 91.04 | 35.95 |
Long-Term Debt Issued | 33.03 | 939.43 | 671.68 | 1,060 | 1,685 |
Long-Term Debt Repaid | -103.79 | -651.45 | -682.71 | -1,036 | -1,696 |
Net Debt Issued (Repaid) | -70.76 | 287.98 | -11.03 | 23.75 | -11.24 |
Issuance of Common Stock | - | - | - | - | 1.08 |
Repurchase of Common Stock | -47.04 | -90.22 | - | - | - |
Other Financing Activities | -0.26 | -13.59 | -0.27 | -0.77 | -0.19 |
Financing Cash Flow | -118.06 | 184.17 | -11.3 | 22.97 | -10.35 |
Foreign Exchange Rate Adjustments | 3.43 | -3.16 | 0.39 | -0.34 | -1.44 |
Net Cash Flow | -62.87 | 349.73 | -57.31 | 18.48 | 62.5 |
Free Cash Flow | -190.82 | -208.5 | -44.47 | -119.77 | 6.18 |
Free Cash Flow Growth | - | - | - | - | 6.68% |
Free Cash Flow Margin | -31.44% | -29.24% | -5.15% | -11.93% | 0.35% |
Free Cash Flow Per Share | -0.25 | -0.30 | -0.06 | -0.17 | 0.01 |
Cash Interest Paid | 37.94 | 20.88 | 8.14 | 7.42 | 8.52 |
Cash Income Tax Paid | 24.46 | 10.01 | 3.71 | 8.04 | 5.97 |
Levered Free Cash Flow | -131.25 | -128.8 | 16.65 | 250.37 | -235.06 |
Unlevered Free Cash Flow | -68.7 | -101.11 | 23.87 | 256.75 | -224.05 |
Change in Working Capital | -41.18 | 32.18 | 21.8 | 42.65 | -20.48 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.